NEW YORK, May 11, 2026 (GLOBE NEWSWIRE) -- Progyny, Inc. (Nasdaq: PGNY), a global leader in women’s health and family building solutions, today announced that Progyny’s Chief Executive Officer, Pete...
Progyny (NASDAQ:PGNY) reported what management called a strong start to 2026, with first-quarter revenue reaching a record level and profitability exceeding expectations amid continued investments in its...
Progyny’s (NASDAQ:PGNY) Q1 CY2026 Sales Beat Estimates, Stock Soars
Reports Record First Quarter Revenue of $328.5 Million Early Selling Season Activity Reflects Robust Demand for Women's Health and Family Building Solutions Returned Value to Shareholders Through Repurchase...
Barchart Research What to Expect from PGNY Earnings PGNY Generated May 6, 2026 Current Price $18.70 EPS Estimate $$0.23 Consensus Rating Strong Buy Average Move 13.73% Progyny Reports Thursday: Can Fertility...
Progyny (PGNY) Q1 Earnings Report Preview: What To Look For
NEW YORK, April 23, 2026 (GLOBE NEWSWIRE) -- Progyny, Inc. (Nasdaq: PGNY), a global leader in women’s health and family building solutions, will report its financial results for the quarterly period...